SEER:NASDAQ, Seer, Inc.
SEER stock overview
Seer, Inc. (SEER:NASDAQ) closed at $1.97 on October 23, 2026,
unchanged on the day.
The stock trades 18.3% below its 52-week high of $2.41
and 27.1% above its 52-week low of $1.55.
Over the past year, it lost 14.7%.
Seer, Inc. is part of the Health Care sector.
Key figures
- Price
- $1.97
- Day change
- 0.00%
- Volume
- 146,978
- Average volume
- 449,446
- Market cap
- 109M+
- 52-week range
- $1.55 – $2.41
- 50-day average
- $2.02
- 200-day average
- $1.92
Price action over the past year
In 252 trading sessions since October 23, 2025, SEER closed higher on 89 days (35%).
Its best day was July 6, 2026 (+35.19%) and its worst was February 27, 2026 (-17.31%).
The stock moved 10% or more in a single session 3 times.
It opened at least 5% above the previous day's high 2 times.
Recent signals
SEER news
-
Oct 21, 2026:
Seer to Report Third Quarter 2026 Financial Results on November 10, 2026
-
Sep 23, 2026:
Seer and Nanyang Technological University to Present Early Findings from Landmark PRECISE-SG100K Proteomics Study at HUPO 2026
-
Sep 21, 2026:
Seer Announces CFO Transition
-
Sep 16, 2026:
Seer Surpasses 100 Peer-Reviewed Customer Publications, Validating a New Era of Deep Proteomics at Scale
-
Sep 4, 2026:
Radoff-JEC Group Calls on Meeta Gulyani to Immediately Resign from Seer, Inc.s Board of Directors
-
Sep 4, 2026:
Radoff-JEC Group Calls on Meeta Gulyani to Immediately Resign from Seer, Inc.'s Board of Directors
-
Aug 18, 2026:
Seer (SEER) Q2 2026 Earnings Call Transcript
-
Aug 13, 2026:
Radoff-JEC Group Calls on Seer, Inc.'s Board of Directors to Publicly Acknowledge That the Company Needs to Be Taken Private and Disclose Timeline for Evaluating Latest Acquisition Offers
About Seer, Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access across the proteome.
Similar stocks
Find more stocks like SEER with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.